Skip to main content
Caplight Logo









EnChannel Medical

EnChannel Medical

Private
GuangzhouHealthcare & Life Scienceshttps://enchannel.com/

Last Round

Series B

May 1, 2025

Total Funding Raised

$110.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EnChannel Medical is a surgical devices company that develops a cardiac electrophysiology platform for precise mapping and targeted treatment of complex heart rhythm disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

pulsed-field ablationPFAcardiac mappingatrial fibrillation treatmentelectrophysiologycardiac ablationnon-thermal ablationablation cathetermapping catheterAI cardiac mappingMedTechcardiac arrhythmiaAcQMap

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnChannel Medical Comparables

Compare EnChannel Medical with similar companies based on industry and business-model similarity.

EnChannel Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Argá Medtech
86%
Cortex, Inc.
81%
Pulsecare Medical
81%

EnChannel Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2025
Series AAug 1, 2023

Key People

Founding team and executive leadership

Jun Feng

CEO & Co-Founder

Founding Team

Min Zhu

Chief Technology Officer

Executive Team

EnChannel Medical Investors

Notable investors and investment history

EnChannel Medical investors
InvestorRounds
Lapam CapitalSeries B
Lilly Asia VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 25, 74% of headcount.

EnChannel Medical Filings

Explore SEC and related filing metadata, where available.

EnChannel Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EnChannel Medical's valuation, stock price, and market status.

Is EnChannel Medical a public or private company?

EnChannel Medical is a private company.

What is the current stock price of EnChannel Medical?

EnChannel Medical is a private company with no public stock price. No recent secondary market data is available.

How much is EnChannel Medical worth (valuation)?

Valuation information for EnChannel Medical is not publicly available.

Can I buy EnChannel Medical stock?

EnChannel Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EnChannel Medical's last funding round?

Funding round information for EnChannel Medical is not publicly available.

Who are the main investors in EnChannel Medical?

Investor information for EnChannel Medical is not publicly disclosed.

Will EnChannel Medical IPO soon?

No public IPO plans have been announced for EnChannel Medical.

How can I track EnChannel Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EnChannel Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGuangzhou
Employee Range27
Year Founded2020
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?